■ March 4, Thursday
■ March 5, Friday
■ March 4, Thursday ( 6th floor, GTC 9:00 - 17:10 )
Opening Remarks
[Director for AIDS gCOE, Kumamoto Univ.]
| Plenary Talk Ⅰ and Joint SessionⅠ | 9:50-12:00 〔130〕 |
|---|---|
| Chairs: Takamasa Ueno and Hirotomo Nakata |
 |
01 | Paul L. Boyer [ National Cancer Institute, USA ] |
Slowing the Speeding Train: NRTIs versus HIV-1 Reverse Transcriptase |
 |
02 | Takeo Kuwata [ Kumamoto Univ. ] |
Contribution of antibody response to effective viral suppression and progression of disease during SIV infection |
 |
03 | Ryuta Sakuma [ Tokyo Medical and Dental Univ. ] |
Rhesus Monkey TRIM5alpha Mediated-Late Restriction of HIV-1 Lifecycle |
 |
04 | Guillaume B.E. Stewart-Jones [ University of Oxford, UK ] |
Structural basis for T-cell receptor recongnition of HIV-1 epitopes in MHC class I |
| Parallel SessionⅡ: Immune ResponsesⅠ |
14:00-15:30 〔90〕 |
|---|---|
| Chairs: Madoka Koyanagi and Kazutaka Honda |
 |
05 | Masao Hashimoto [ Kumamoto Univ. ] |
Comprehensive analysis of escape mutation from HIV-1-specific cytotoxic T cells restricted by Asian allele HLA-B*5401 |
 |
06 | Tetsuo Tsukamoto [ University of Tokyo ] |
Benefit of single epitope-specific CD8+ T-cell memory induction without virus-specific CD4+ T-cell help for immunodeficiency virus control |
 |
07 | Chihiro Motozono [ Kumamoto Univ. ] |
T cell receptor cross-reactivity toward variant HIV antigens is dependent on cognate peptide specificity |
 |
08 | Jeffrey J. Ishizuka [ Harvard Medical School, USA ] |
Models of Protection and Pathogenesis in HIV-1 Immune Activation |
| Parallel SessionⅡ: PathogenesisⅠ |
16:00-17:10 〔70〕 |
|---|---|
| Chairs: Shigeyoshi Harada and Terumasa Ikeda |
 |
09 | Ranya Hassan [ Kumamoto Univ. ] |
A unique function of HIV-1 Nef that depends on its highest affinity host factor Hck |
 |
10 | Masateru Hiyoshi [ Kumamoto Univ. ] |
Molecular mechanism by which HIV-1 Nef-Hck axis induces the Golgi dys-function |
 |
11 | Kei Sato [ Kyoto Univ. ] |
A novel HIV-1 infection model using humanized mice |
■ March 4, Thursday ( 2nd floor, CAIDS 14:00 - 17:10 )
| Parallel SessionⅢ: Drug ResistanceⅠ |
14:00-15:30 〔90〕 |
|---|---|
| Chairs: Kazuhisa Yoshimura and Yasushi Tojo |
 |
12 | Shigeyoshi Harada [ Kumamoto Univ. ] |
In vitro selections of raltegravir resistant variants using diverse primary isolates, subtype B, C, CRF01_AE, and CRF08_BC |
 |
13 | Masako Nishizawa [ National Institute of Infectious Diseases ] |
Analyses of minority drug-resistant populations in newly-diagnosed HIV/AIDS patients in Japan using highly sensitive allele-specific PCR |
 |
14 | Kazuhiko Ide [ Kumamoto Univ. ] |
Novel HIV-1 protease inhibitors (PIs) containing bis-tetrahydrofuran (bis-THF) and a novel polycyclic ligand |
 |
15 | Hiromi Aoki [ Kumamoto Univ. ] |
Early phase dynamics of HIV-1 infection in hPBM-transplanted NOD/SCID/Jak3-/- mice using infectious HIV-1 carrying fluorescent protein mCherry |
| Parallel SessionⅣ: Drug ResistanceⅡ |
16:00-17:10 〔70〕 |
|---|---|
| Chairs: Nobuyo Kuwata and Hiromi Aoki |
 |
16 | Takashi Masaoka [ Nagoya Medical Center ] |
Novel high-throughput phenotypic resistance assay for HIV-1 protease using wheat cell-free protein production system |
 |
17 | Masayuki Amano [ Kumamoto Univ. ] |
Inserts in Gag Proteins Elicit Degradation of the Gag Proteins in Multi-drug-resistant HIV Variants |
 |
18 | Manabu Aoki [ Kumamoto Univ. ] |
The binary mechanism of HIV-1 resistance to tipranavir(TPV): Loss of inhibition of protease catalytic activity and protease dimerization |
 |
 |